All In MedTech

Device Trial Radar · NCT06940648

Virtuoso Improving Anatomic Bladder Lesion Excision (VIABLE) Trial

Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

30

Planned (sponsor's estimate)

Start

Apr 17, 2025

Primary completion

Sep 2026

Study completion Sep 2026

Sponsor

Lead sponsor
Virtuoso Surgical, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Chinese University of Hong Kong
First posted
Apr 23, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A robotic assisted surgery for bladder lesion excision.

Conditions

  • Bladder Neoplasm

Interventions

  • The study is to evaluate the use of the Virtuoso Endoscopy System to perform safe and effective bladder lesion excisions.Device

    This study is to evaluate the use of the Virtuoso Endoscopy System (VES), which is a robotic enhanced system, to perform safe and effective bladder lesion excisions.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Detrusor muscle presence in the pathologic specimen after VES procedureTime frame: Through study completion, an average of 30 days

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Prince of Wales Hospital, Chinese University of Hong Kong

    Hong Kong, Hong Kong, Hong Kong

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.